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 Construction and Validation of the Fatigue Impact and Severity Self-Assessment for 
Youth and Young Adults with Cerebral Palsy 
 
Abstract 
 
Purpose: The Fatigue Impact and Severity Self-Assessment (FISSA) was created to 
assess the impact, severity and self-management of fatigue for individuals with 
cerebral palsy (CP) aged 14-31. 
Methods Used: Items were generated from a review of measures and interviews 
with individuals with CP. Focus groups with healthcare professionals were used for 
item reduction. A mailed survey was conducted (n=163/367) to assess the factor 
structure, known-groups validity and test-retest reliability. 
Results Obtained: The final measure contained 31-items in two factors and 
discriminated between individuals expected to have different levels of fatigue. 
Individuals with more functional abilities reported less fatigue (p< 0.002) and those 
with higher pain reported higher fatigue (p< 0.001). The FISSA was shown to have 
adequate test-retest reliability, ICC(3,1)=0.74 (95% CI 0.53-0.87). 
Conclusions Reached: The FISSA valid and reliable for individuals with CP. It allows 
for identification of the activities that may be compromised by fatigue to enhance 
collaborative goal setting and intervention planning. 
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 1. Introduction 
Fatigue has been identified as one of the top three cerebral palsy (CP)-related 
impairments in adulthood that can affect activities of daily life [1]. Approximately 
20% of physicians reported a noticeable functional deterioration in the adults with 
CP they treat [1]; some self-reported causes of such deterioration include spasticity, 
fatigue, pain and lack of physical training [2, 3]. Fatigue has been shown to be more 
prevalent in adults with CP compared to the general population [4]. A 20% 
prevalence of fatigue in a sample of adults with CP has been reported and notably, 
41% of those individuals were classified as severely fatigued [5]. Individuals who 
reported severe fatigue were 2.3 times more likely to report concurrent chronic 
pain and 3.4 times more likely to report concurrent depressive symptoms [5]. In 
addition, there are reports that fatigue may play a role in physiological burnout 
experienced by adults with CP. Deficits in muscle function, combined with the 
natural history of CP and the development of secondary conditions (such as fatigue) 
during growth and maturation, have been hypothesized to lead to functional 
deterioration and early loss of mobility [6, 7], the specific role fatigue may play in 
this cycle remains unknown. In a personal reflection, Jones [3] discussed her 
experience of aging with CP and discussed the need to better understand the 
prevention and management of secondary conditions such as fatigue.  
There are numerous published scales available to measure fatigue; however, 
none have been validated for use in a population of individuals with CP. The 
purpose of this study was to create and validate a new measure of fatigue, the 
Fatigue Impact and Severity Self-Assessment (FISSA), to gain a better understanding 
 of fatigue experienced and to enhance self-management of fatigue for individuals 
with CP. 
2. Methods 
Phase 1 – Initial item generation 
 As part of a larger study, a search was conducted in the CINAHL and EMBASE 
databases for articles that assessed the psychometric properties of published fatigue 
scales [8]. Fatigue scales identified in the search were then reviewed and items were 
identified based on relationships to themes in the existing literature. Secondly, items 
were generated based on the themes discussed by individuals with CP in a 
phenomenological inquiry (n=10) described elsewhere [9]. The collated items were 
rephrased to enhance relevance and to simplify or standardized the language and 
formatted into a new questionnaire.  
Phase 2 – Item reduction and refinement 
Two focus groups were then held with healthcare providers at children’s 
treatment centres in Ontario, Canada. Healthcare professionals who normally treat 
individuals with CP helped reduce the number of items to a small, relevant subset of 
questions [8]. Involving expert clinicians in the refinement of this measure enhances 
the content validity, which strengthens the clinical inferences that may be drawn 
from the questionnaire [10]. 
A modified nominal group technique [11] was used to reduce the items from 
the scale, and to add items that that were overlooked in the previous stages of item 
generation. The use of both activities (reduction and addition of new items) ensured 
balance between preserving a high level of content validity, creating a feasible 
 questionnaire, limiting respondent burden and incorporating the perspectives of 
service providers who work with individuals with CP.  
Phase 3 - Feasibility testing 
Ten questionnaires were distributed to individuals with CP between the ages 
of 14 and18 years from children’s treatment centres in Ontario, Canada; who were 
classified as level I or II on the Communication Function Classification System 
(CFCS) [12] and as levels I to IV on the Expanded and Revised Version of the Gross 
Motor Function Classification System (GMFCS-ER) [13]. Participants were asked to 
read the FISSA and complete a feasibility questionnaire to ensure that the items 
were comprehensible, unambiguous and easy to respond to. This step was 
considered a separate assessment of the content validity of the scale. 
Phase 4 – Psychometric assessment 
A large survey mailing was used to assess the psychometric properties, 
specifically the factor structure, known-groups validity, internal consistency and 
test-retest reliability, of the FISSA. A total of 367 youth and young adults with CP 
were contacted as potential participants for the study from participating children’s 
rehabilitation centres in Ontario, Canada, previous research studies, existing 
facebook groups for individuals with CP and through the Ontario Federation for 
Cerebral Palsy website and newsletter. Due to the diverse recruitment methods, 
individuals of all functional ability levels elected to participate. Study eligibility 
criteria included individuals aged 14 to 31 years of age, English speaking and the 
ability to complete the questionnaire with some degree of independence. Returned 
surveys that were completed entirely by parental proxy were excluded from the 
 study. In addition to the FISSA, a self-report version of the GMFCS-ER [13] was used 
to collect information on the participants’ level of functional ability. Other measures 
included a simple demographic questionnaire used to obtain self-reported 
distribution of involvement, age and sex and a pain questionnaire to collect 
information on prevalence, severity, impact and location of pain [14]. The final page 
of the survey booklet asked for information regarding the amount of assistance 
required to complete the survey.  
 The study followed a modified Dillman method [15]. All potential 
participants initially received a full survey package (either a hard copy or a link to 
an online version of the survey materials). A reminder letter was mailed (or 
emailed) to each potential participant approximately two weeks following the initial 
mailing. All individuals who had not returned or completed the survey two weeks 
after the reminder letters were sent received a second full questionnaire package or 
an email containing the original link. To assess the test-retest reliability of the FISSA 
and pain questionnaires, a small subset of the sample were asked to complete these 
portions of the survey a second time approximately two weeks after their initial 
response. All phases of this study received ethical approval from the ethics review 
boards at Western University, McMaster University and specific clinical sites as 
appropriate. Each individual participant provided written informed consent, or in 
case of the survey, completion implied consent, to participate in this study.  
An exploratory factor analysis was conducted using principal components 
analysis on the final data set obtained from the FISSA. Prior to conducting the factor 
analysis, the data were screened for suitability using inspection of the magnitude of 
 correlations among items [16], the Kaiser-Meyer-Olkin measure of sampling 
adequacy and Bartlett’s test of sphericity. Cattell’s Scree test and parallel analysis 
were used to determine the number of factors extracted and retained for the 
remainder of the analysis. The remaining factors were then rotated to better 
understand the meaning of each factor using the direct oblimin approach as it was 
hypothesized that the factors would be related. A final model was then created to 
explain the underlying structure of the questionnaire and to understand how the 
factors were acting in the scale.  
The known groups validity of the FISSA was examined by investigating the 
difference in fatigue score by GMFCS level and between high and low pain 
(represented by both severity and impact of pain). GMFCS levels were grouped 
together to increase the subgroup sample size and consisted of individuals who self-
classified as level I separately, levels II and III were grouped together and levels IV 
and V formed the third group. The Kruskal-Wallis statistic was used to compare the 
difference in fatigue between groups of GMFCS levels. A median split was applied to 
the pain severity and impact data and a Mann-Whitney U was used to assess the 
difference in fatigue by pain level. Internal consistency of the FISSA was assessed 
using Cronbach’s alpha. Test-retest reliability of the FISSA and pain questionnaire 
were analysed using an intraclass correlation, specifically the ICC(3,1) model was 
used [17]. 
3. Results 
Phase 1 – Initial item generation 
 The initial draft of the scale comprised 50 items. Forty-four items were 
selected from 9 different fatigue scales identified in the review [8]. Furthermore, the 
author created 6 additional items to represent concepts discussed in the interviews 
conducted with youth and young adults with CP in the study by Brunton and 
Bartlett [9]. 
Phase 2 – Item reduction and refinement 
 A total of 11 healthcare professionals (5 Physical Therapists, 3 Occupational 
Therapists, 1 Recreation Therapist/Kinesiologist, 1 Nurse and 1 Physiatrist) 
participated in one of two focus groups. The initial focus group resulted in removal 
of 11 items, rephrasing the remaining items for consistency and clarity, and the 
addition of 4 items to the questionnaire. The second focus group resulted in removal 
of 3 items and the addition of 4 items. The participants in the second focus group 
informed the draft definition of fatigue as follows ‘Please answer the following 
questions about your experience with fatigue. For the purposes of this questionnaire 
we would like you to think about fatigue in terms of: physical tiredness, muscle 
soreness, exhaustion of your muscles and body, or any related feeling. When 
answering the questions, please try to focus on fatigue as it is defined above and not 
pain you may experience that is different from muscle soreness’. 
 Response options were then set to a 1 to 5 Likert scale, allowing for a neutral 
option and anchors provided on each number from ‘Completely Disagree’ to 
‘Completely Agree’. This scale was chosen to align with the scaling requirements for 
a reliable discriminative measure [18, 19]. Several questions related to the severity 
of fatigue were given a variety of scaling options as related to individual questions 
 as appropriate. Specifically, 5 questions regarding severity and variability of fatigue 
were given separate scaling options. Questions asking about level of fatigue on the 
most and least fatiguing days and on the average day were scaled to have the labels 
reflect “No Fatigue” to “Severe Fatigue” with the middle label representing 
“Moderate Fatigue”. Similarly question 16 “On average, how much of the day do you 
feel fatigued?” was scaled to divide the day into quarters and provide a no fatigue 
option. Question 17 “For how many days last week did you feel fatigued at least part 
of the day?” was scaled according to the possible 7 days in a week. It was felt that 
these changes  were required to accurately capture meaningful information 
regarding fatigue severity and variability that could not be captured in with the 
scoring system used in the rest of the measure. Finally, a timeframe of 7 days was 
added to the questionnaire to orient users to consider the same timeframe when 
completing the questionnaire. 
Phase 3 - Feasibility testing 
 Five feasibility questionnaires were returned completed; two individuals 
withdrew from the project - one due to the time required to complete the 
questionnaire and one due to feeling overwhelmed by the impact of fatigue on their 
daily life as a result of reading the questionnaire. The remaining three 
questionnaires were not returned for unknown reasons. Three participants felt that 
the FISSA was easy or not too difficult to understand, with one participant needing 
help understanding the meaning of some words. The final participant found the 
impact section of the questionnaire confusing and felt it was only relevant to 
individuals who were ambulatory. Four of the five participants indicated that the 
 response options were appropriate given the questions that were being asked and 
on consideration of this feedback, no changes were made to the FISSA [8].  
Phase 4 – Psychometric assessment 
 Of the 367 individuals contacted, 163 questionnaires were returned over the 
course of the study, for a response rate of 44.4%. A final convenience sample of 130 
youth and young adults with CP participated in the study by returning a 
questionnaire (completed at least semi-independently). Figure 1 provides a detailed 
breakdown of the returned questionnaires. Table 1 contains the participant 
characteristics and demographic information of the 130 participants.  
 During the data screening for adequacy for factor analysis the internal 
consistency of the 32 items together was 0.95. The non-parametric Spearman’s Rho 
correlations did not reveal any correlations above 0.9 and 62% of the correlations 
were above 0.3, the Kaiser-Meyer-Olkin measure of sampling adequacy was 
demonstrated to be 0.90, which is considered to be excellent [20], and Bartlett’s test 
of sphericity was found to be significant (p< .001) all indicating that the data set was 
appropriate for factor analysis. Based on Cattell’s Scree plot and parallel analysis, 
two factors (Impact of Fatigue on Daily Living and Management and Activity 
Modification) were retained in the factor structure of the FISSA and together they 
explained 48.7% of the variance. The Impact factor explained 42.5% of the variance 
and the Management and Modification Factor explained an additional 6.2% of the 
variance in fatigue scores. Item loadings found to be 0.4 or greater were considered 
significant [21]. In total 17 items loaded on the first factor (Impact of Fatigue on 
Daily Living) and 15 items loaded on the second factor (Management and Activity 
 Modification). One item (Fatigue interferes with my participation in social activities) 
loaded moderately on both factors; however, it is considered to be part of the first 
factor given its slightly larger loading. Finally one item (Fatigue interferes with my 
ability to control my mood) did not load sufficiently on either factor and was 
removed from the scale, resulting in a final 31-item version of the FISSA (Appendix 
A). Refer to Table 2 for the individual factor loadings.  
 Table 3 contains the descriptive information of the FISSA score by grouped 
GMFCS level, and low or high pain level. Individuals classified as GMFCS level I 
experienced significantly less fatigue than individuals classified in any other GMFCS 
level (II-V) (p< 0.001). Individuals classified as GMFCS level IV or V did not 
experience significantly more fatigue when compared to individuals classified as 
GMFCS level II or III regardless of whether the total score (p= 0.063) or the 
individual factor scores were assessed (Impact p=0.069; Management p=1.0). 
Individuals with higher pain (both impact and severity) reported higher total FISSA 
scores and higher individual factor scores (p< 0.001).   
 The Cronbach’s alpha for the 31-item FISSA was 0.95. The average test-retest 
interval in this study was 36 days (range 13 to 87 days). A total of 31 individuals 
returned their test-retest package completed. The FISSA as a whole demonstrated 
moderate reliability with an ICC(3,1) = 0.75 (95% CI 0.54-0.87). The pain 
questionnaire demonstrated an ICC(3,1) = 0.73 (95% CI 0.50-0.86) for the impact 
component and an ICC(3,1) = 0.78 (95% CI 0.59-0.89) for the severity component.  
4. Discussion 
  A new fatigue scale, the FISSA, was created using a variety of methods to 
ensure relevance to the users of the scale: youth and young adults with CP and their 
healthcare providers. A review of fatigue measures in the context of knowledge of 
the clinical course of CP allowed for inclusion of items known to be related to fatigue 
in CP. The interviews described in the study by Brunton and Bartlett [9] provided a 
client-centered approach to item generation and selection to enhance the 
applicability of the questionnaire to individuals with CP. The healthcare providers 
who participated in focus groups offered an expertise-based method of reducing 
and adding items to the scale to balance respondent burden while retaining a 
complete and relevant set of items. The FISSA was then pilot tested in a sample of 
youth and young adults with CP to ensure the questions were easily understood and 
completed by potential users of the scale. One participant posed the question ‘Why 
do my muscles ache when I am fatigued?’ to her doctor as a result of reading and 
completing the questionnaire, providing evidence that the FISSA is prompting 
individuals to think about fatigue and the consequences of activity, which may 
contribute to the development of self-awareness [8]. 
 An exploratory factor analysis and a known groups validation approach 
were used to provide evidence of content and construct validity of the FISSA as 
there is currently no accepted measure available to provide information about 
fatigue in individuals with CP. The FISSA demonstrated a related 2-factor solution 
that explained 49% of the variance and was able to discriminate between groups 
expected to experience more fatigue (individuals classified as having more 
functional impairment according to the GMFCS and individuals experiencing a high 
 degree of pain, both in terms of severity and impact). Finally, the FISSA was shown 
to be reliable with a high degree of internal consistency and a moderate correlation 
coefficient over a period of time where no change was expected. 
 Many individuals (regardless of GMFCS level) live with fatigue as a 
consequence of daily activities [22] and there are limited strategies available to 
these individuals to effectively manage their fatigue. There is a great need to 
understand how fatigue is impacting a client’s life and the ability to accomplish 
activities of daily living [23]. The FISSA was created with this goal in mind: to assist 
with identifying individuals who are experiencing fatigue related to CP and as a 
method of fostering a clinical discussion between clinicians and their clients about 
fatigue and possible management strategies. The FISSA provides a preliminary 
description of activities that fatigue interferes with, an overview of the severity of 
fatigue experienced by the individual and a report on the management strategies 
that an individual may or may not have tried to effectively limit or manage their 
fatigue. Early identification of fatigue and the activities that are most affected may 
assist with intervention selection to interrupt the cycle of deconditioning described 
in individuals with CP [7]. The progression of the activity limitations in CP as a 
result of fatigue are thought to be linked to functional decline that can affect 
independence in adult life [7]. Once fatigue is identified, strategies and adaptions to 
increase fatigue management in specific areas may be more easily conceivable and 
available to these individuals. This self-assessment can be used on an individual 
basis to streamline a clinical conversation to the salient fatigue-related issues. For 
example, fatigue experienced in community settings that require long distance 
 ambulation or activities that are of a long duration might be managed and mitigated 
by initiating discussions on the use of powered mobility. The goal would be to 
highlight the individual’s ability to increase their engagement in the activity while 
recognizing that fatigue may be a limiting factor. Another example would be 
discussing the opportunities for rest or napping during a typical day or week to 
manage fatigue that accumulates or changes based on daily or weekly tasks. The 
FISSA may help clinicians effectively discuss possible solutions and strategies to 
limit or manage the impact of fatigue that is specific to the individual (i.e. daily or 
weekly patterns of fatigue, specific challenges or activities) while being mindful of 
limited time and resources in the clinical setting. 
Limitations 
 Several authors have suggested a ratio of between five to ten participants 
per item when determining sample size adequacy for factor analysis. This is a 
limitation in this study as the ratio of participants to items was 4:1. However, these 
guidelines have been challenged [24] and it was found that changes to the 
participant to item ratio made little difference in the stability of the factor solution 
when parallel analysis was used as the primary extraction method. In addition, it 
has been argued that factors that contain four or more loadings of 0.60 or higher are 
reliably extracted regardless of the sample size [25].  In the case of the FISSA, both 
factors readily met this criterion. The FISSA was unable to discriminate individuals 
classified as GMFCS Level II and III from those classified as GMFCS Level IV and V, 
this could have been due to the relatively small subgroup sample sizes and should 
be investigated with a larger study in the future. Presently the FISSA has only been 
 validated for use as a discriminative measure. Future validation efforts are needed 
prior to using the FISSA as a predictive or evaluative measure. The authors of this 
study plan to continue to evaluate the validity of the FISSA in terms of it’s utility as a 
predictive and/or evaluative measure. Similarly, ongoing use of the FISSA in both 
clinical practice and research will allow for evolution of the measure through 
increased refinement of items and through additional testing of the factor structure 
and subscale profiles. Finally, more research is needed regarding the effectiveness 
of fatigue management strategies used by individuals with CP.  
Conclusion 
 The FISSA represents a valid and reliable tool that can be used to identify 
individuals who have a significant impact of fatigue on their lives. We hope that 
clinicians will use the FISSA to initiate conversations about the functional 
restrictions individuals are experiencing as a result of fatigue and use the measure 
as a starting point for discussion about possible management strategies. Jones [3] 
recognized the need to identify and collaborate on interventions to address 
functional problems; the FISSA can facilitate this collaboration. Clinicians can 
examine the responses to individual items of the FISSA as a method of identifying 
the specific areas of the individual’s life that fatigue is impacting most, especially 
given the highly individualized presentation of CP. Ideally, the FISSA will then be 
used to facilitate collaborative goal setting and future intervention planning 
between clinicians and their clients and families. 
  
 Declaration of Interest 
This work was supported through a Canadian Doctoral Student Scholarship 
awarded to L. Brunton from the Canadian Institutes of Health Research. 
 
  
Appendix A 
  © Brunton, 2014.  “Copy Freely – Do NOT Change” 
 
Fatigue Impact and Severity Self-Assessment (FISSA) 
 
Please answer the following questions about your experience with fatigue. For the 
purposes of this questionnaire we would like you to think about fatigue in terms of: 
• physical tiredness  
• muscle soreness  
• exhaustion of your muscles and body 
• or any related feeling 
When answering the questions, please try to focus on fatigue as it is defined above and 
not pain you may experience that is different from muscle soreness.  
 
Impact Scale 
Completely      Somewhat        Neither Agree             Somewhat    Completely 
Disagree        Disagree      nor Disagree       Agree         Agree 
      1     2   3                  4  5 
  
Using the scale above and thinking about a typical week (7 days), to what extent do you 
agree with the following statements?  
 
Fatigue interferes with …  
1.  my general everyday activities 1 2 3 4 5 
2.  my ability to move around indoors 1 2 3 4 5 
3.  my ability to do things on my own 1 2 3 4 5 
4.  my ability to move around in my community 1 2 3 4 5 
5.  my ability to get outside of my house 1 2 3 4 5 
6.  my ability to finish things 1 2 3 4 5 
7.  my participation in social activities 1 2 3 4 5 
8.  my ability to start things 1 2 3 4 5 
9.  my ability to take care of myself (examples: dressing, eating, bathing, 
brushing my teeth/hair, toileting etc.) 
1 2 3 4 5 
 
In addition,  
10. I use adaptive equipment to manage my fatigue (examples: a walker, 
manual wheelchair, power wheelchair etc.) 
1 2 3 4 5 
11. I have had to reduce my work responsibilities outside of my home 
because of fatigue (examples: school work, job-related work, 
volunteering etc.) 
1 2 3 4 5 
12. I have had to reduce my responsibilities at home because of fatigue 1 2 3 4 5 
Appendix A 
  © Brunton, 2014.  “Copy Freely – Do NOT Change” 
 
Using the scale given with each question, please think about the last seven (7) days 
and answer the following statements or questions. 
 
13. Rate your level of fatigue on the day within the last week that you felt the most 
fatigued: 
No Fatigue   Moderate Fatigue          Severe Fatigue 
        1             2  3               4         5 
 
 
14. Rate your level of fatigue on the day within the last week that you felt the least 
fatigued:  
No Fatigue   Moderate Fatigue          Severe Fatigue 
        1             2  3               4         5 
 
 
15. Rate your average level of fatigue for the past week: 
No Fatigue   Moderate Fatigue          Severe Fatigue 
        1             2  3               4         5 
 
 
16. On average, how much of the day do you feel fatigued? 
None          A Quarter    Half the Day         Three Quarters           All Day  
                    of the Day                of the Day 
    1    2    3   4                    5  
 
 
 
17. For how many days last week did you feel fatigued at least part of the day? 
 
      1  2           3                     4        5              6         7 
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Management and Activity Modification Scale 
Using the scale below and thinking about a typical week (7 days), to what extent do you 
agree with the following statements?  
 
Completely      Somewhat        Neither Agree             Somewhat    Completely 
Disagree        Disagree      nor Disagree       Agree         Agree 
      1     2   3                  4  5 
 
Fatigue interferes with …  
18.  my enjoyment of life 1 2 3 4 5 
19.  my leisure and recreational activities 1 2 3 4 5 
20.  the length of time I can be physically active 1 2 3 4 5 
21.  my balance and coordination 1 2 3 4 5 
22.  my motivation to do physical activities  1 2 3 4 5 
23.  my motivation to participate in social activities  1 2 3 4 5 
 
In addition,  
 
24.  my muscles ache when I am fatigued 1 2 3 4 5 
25.  long periods of inactivity increase my fatigue 1 2 3 4 5 
26.  stress increases my fatigue 1 2 3 4 5 
27.  fatigue increases my stress 1 2 3 4 5 
28. I pace my physical activities to manage my fatigue 1 2 3 4 5 
29. I think about fatigue when I plan my day 1 2 3 4 5 
30. I limit my physical activity to manage my fatigue 1 2 3 4 5 
31. I stop and rest during activity to manage my fatigue 1 2 3 4 5 
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Additional Questions: 
 
32. Does your level of fatigue change depending on the time of day?  
Yes    (If yes, please answer question 32b)  No 
 
 
32b. What time of day is your fatigue the worst? 
Early Morning    Mid-morning         Noon     Late afternoon        Evening 
       1            2         3     4   5 
  
 
 
33. Does your level of fatigue change depending on the day of the week? 
  Yes    (If yes, please answer question 33b)  No 
 
 
 
33b. On which day of the week are you most fatigued? 
Monday     Tuesday    Wednesday      Thursday    Friday      Saturday      Sunday 
      1  2           3                     4        5              6         7 
 
 
 
34. What factors are responsible for or contribute to your fatigue? 
 
 
 
 
 
 
35. What do you do to reduce or manage your fatigue? 
 
 
 
 
 
 
36. What else could you do to reduce or manage your fatigue? 
 
 
 
 
 
 
37. What could other people do to help reduce your fatigue? 
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Table	1	-	Participant	Characteristics	and	Demographic	Information	of	the	Sample	
Characteristic	 	 Total	(n=130)	
n	(%)	
Sex*	 Male	 									61	(47%)	
	 Female	 									68	(53%)	
	
Age	
	
Mean,	years	(SD)	
Median	
Range	
	
			18.9	(4.5)	
			17	
			14-31	
	
GMFCS	Level 	 I	
II	
III	
IV	
V	
									34	(27%)	
									39	(32%)	
									21	(17%)	
									18	(14%)	
									12	(10%)	
	
Distribution	of	Involvement  	 Monoplegia	
Hemiplegia	
Diplegia	
Triplegia	
Quadriplegia	
									6	(5%)	
									31	(25%)											
									44	(35%)																
									11	(9%)																						
									34	(26%)	
GMFCS=	Gross	Motor	Function	Classification	System;	Note:	*one	participant	did	not	
report	their	sex;	six	participants	did	not	report	GMFCS	level;	  	four	participants	
did	not	report	distribution	of	involvement.	
	
  
Table	2	–	Fatigue	Impact	and	Severity	Self-Assessment	Item	Factor	Loadings	
                                                    Rotated Factor Loadings 
Item Factor 1 – Impact of Fatigue 
on Daily Living 
Factor 2 – Management 
and Activity Modification  
Fatigue interferes with my ability to do 
things on my own 
.77 .03 
I use adaptive equipment to manage my 
fatigue 
.77 -.27 
Fatigue interferes with my ability to take 
care of myself 
.73 -.07 
Fatigue interferes with my ability to move 
around indoors 
.73 .12 
Fatigue interferes with my ability to get 
outside of my house 
.70 .10 
I have had to reduce my work 
responsibilities outside my home because 
of fatigue 
.70 .06 
Fatigue interferes with my ability to move 
around in my community 
.70 .17 
Rate your average level of fatigue for the 
past week 
.70 .18 
I have had to reduce my responsibilities at 
home because of fatigue 
.69 .08 
Rate your level of fatigue on the day 
within the last week that you felt the least 
fatigued 
.68 -.09 
On average, how much of the day do you 
feel fatigued 
.68 .07 
Rate your level of fatigue on the day 
within the last week that you felt most 
fatigued 
.64 .17 
Fatigue interferes with my general 
everyday activities 
.57 .31 
Fatigue interferes with my ability to start 
things 
.50 .18 
For how many days last week did you feel 
fatigued at least part of the day 
.50 .24 
Fatigue interferes with my ability to finish 
things 
.46 .36 
Fatigue interferes with my participation in 
social activities 
.43 .41 
Fatigue interferes with the length of time I 
can be physically active 
.12 .72 
I limit my physical activity to manage my 
fatigue 
-.05 .71 
My motivation to do physical activities .05 .70 
I stop and rest during activity to manage 
my fatigue 
-.01 .68 
Fatigue interferes with my balance and 
coordination 
.03 .68 
	
	 	  
  
Table	3	-	Summary	of	Fatigue	Scores	for	Known	Groups	Validity	Testing	
Construct Subgroups FISSA	Score		
Median,	
(Range) 
FISSA	Impact	
Score	Median	
(Range)	
FISSA	
Management	
Score	Median	
(Range)	
Functional	
Level	
GMFCS	Level	I	
(n=35)	
69	(30,	122)	 31	(16,	62)	 39	(14,	60)	
GMFCS	Level	II	
and	III	(n=63)	
96	(37,	147)	 49	(20,	78)	 49	(14,	66)	
GMFCS	Level	
IV	and	V	
(n=39)	
106	(38,	146)	 57	(21,	83)	 51	(17,	61)	
Pain	Severity	 Low	Pain	
Severity	≤	50th	
percentile	
(n=84)	
75	(30,	146)	 38	(16,	83)	 42	(14,	64)	
High	Pain	
Severity	≥	51st	
percentile	
(n=60)	
109	(39,	157)	 58	(20,	87)	 53	(19,	70)	
Pain	Impact	 Low	Pain	
Impact	≤	50th	
percentile	
(n=79)	
75	(30,	146)	 35.5	(16,	83)	 41.5	(14,	64)	
High	Pain	
Impact	
Severity	≥	51st	
percentile	
(n=63)	
108	(39,	157)	 56	(19,	70)	 53	(19,	70)	
GMFCS=	Gross	Motor	Function	Classification	System		 	  
 
 
 
 
 
 
 
  
Figure 1 – Breakdown of Inclusion and Exclusion of Returned Surveys    
 
